Contents
Download PDF
pdf Download XML
207 Views
102 Downloads
Share this article
Research Article | Volume 13 Issue:3 (, 2023) | Pages 1426 - 1434
MicroRNA 24 as predictor of CAD severity in patients with Acute Coronary syndrome with and without Diabetes mellitus
Under a Creative Commons license
Open Access
Received
July 8, 2023
Revised
July 21, 2023
Accepted
Aug. 28, 2023
Published
Aug. 29, 2023
Abstract

Objective: To compare the levels of microRNA (miRNA) 24 levels in diabetic patients with acute coronary syndrome (ACS)with non-diabetics suffering from ACS. Methodology: A prospective case-control study was carried out among 40 patients with ACS residing in Belagavi, Karnataka, South India. Patient characteristics based on demographics, ACS related information and treatment, biochemical parameters, and miRNA-24 levels were compared between diabetics and non-diabetics. Finally, miRNA-24 was evaluated for effectiveness as a clinical biomarker for CAD severity in ACS pateints in both the groups. Results: The majority of patients were males between the age group of 18 and 77 years living in urban areas with physical activities restricted to NHYA class 2.  A significant level of differences was found between the cases and controls inpatient characteristics such as duration of diabetes diagnosis, treatment of diabetes, family history of diabetes, comorbidities, random blood sugar and HbA1c. Within the levels of miR-24 also, significant variation was observed between the diabetics and non-diabetics. The ROC analysis for evaluating the efficiency of miR-24 as a clinical biomarker for diabetic patients with ACS was established.  Conclusions: The control (non-diabetic) group showed significant CT values of miRNA-24 compared to diabetics, suggesting an up-regulation of mi-RNA and thereby may play a protective role of miRNA-24 in these patients. Moreover, the ROC analysis for fold change in miRNA-24 level in diabetic patients with ACS was found to be significant, suggestive of a possible link between expression of miRNA-24 and glucose levels. Therefore, the current study supports the use of miRNA-24 as a prognostic marker inACS outcome.

Keywords
Recommended Articles
Research Article
A retrospective study of prevalence of deaths due to Poisoning in a tertiary care Hospital
...
Published: 26/08/2024
Download PDF
Research Article
Clinico-Hematological Profile of Anaemia Among Paediatric Patients: A Hospital-Based Study
Published: 23/03/2022
Download PDF
Research Article
Study of Clinical Profile of Primary Headache Disorders and Its Effect on Quality of Life
...
Published: 15/09/2025
Download PDF
Research Article
Comparison of Conventional Dose of Bupivacaine and Low-Dose Bupivacaine-Fentanyl Spinal Anaesthesia in Maintaining Hemodynamic Stability in Patients Undergoing Transurethral Resection of Prostate
Published: 10/06/2022
Download PDF
Chat on WhatsApp
Copyright © EJCM Publisher. All Rights Reserved.